XML 12 R4.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 17,203 $ 10,408
General and administrative 5,119 3,926
Total operating expenses 22,322 14,334
Loss from operations (22,322) (14,334)
Other income:    
Interest and other income, net 4,130 2,454
Total other income 4,130 2,454
Net loss (18,192) (11,880)
Unrealized loss on marketable securities available-for-sale, net (387) 0
Comprehensive loss $ (18,579) $ (11,880)
Net loss per share, basic $ (0.35) $ (0.28)
Net loss per share, diluted $ (0.35) $ (0.28)
Weighted average Number of shares outstanding, Basic 52,228,934 42,394,623
Weighted average shares number of shares outstanding, Diluted 52,228,934 42,394,623